Eduardo Freire Rodrigues

Eduardo Freire Rodrigues

Eduardo Freire Rodrigues

Co-founder, CEO of UpHill

Freire Rodrigues is the Portuguese co-founder and CEO at UpHill, whose SaaS helps healthcare professionals keep up-to-speed on the latest clinical treatments and protocols using AI. 

He also continues to be an invited assistant teacher at Lisbon’s NOVA Medical School’s Faculty of Medical Sciences, where he completed a master’s in Medicine and worked full-time for three years prior to UpHill. He additionally collaborates in public healthcare at the ARSLVT healthcare company in Lisbon. He has worked as a resident physician at public hospitals in Lisbon and Paris.

Freire Rodrigues also completed clinical scholars research training at Harvard Medical School and gained a qualification in Information Management and Business Intelligence in Healthcare at NOVA Information Management School in Lisbon.

Limited Reading

The rest of the content is only available if you are logged in.

Limited Reading


Gift This Article

The gift link can be opened by one recipient only.

You have 19 gift credits left this month

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.